These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8780636

  • 21. Phospholipid fatty acid composition and diamine oxidase activity of intestinal mucosa from rats treated with irinotecan hydrochloride (CPT-11) under vegetable oil-enriched diets: comparison between perilla oil and corn oil.
    Usami M, Ohata A, Kishimoto K, Ohmae K, Aoyama M, Miyoshi M, Fueda Y.
    JPEN J Parenter Enteral Nutr; 2006; 30(2):124-32. PubMed ID: 16517957
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fecal SN-38 Content as a Surrogate Predictor of Intestinal SN-38 Exposure and Associated Irinotecan-induced Severe Delayed-Onset Diarrhea by a Novel Use of the Spectrofluorimetric Method.
    Zheng Z, Šaponjac VT, Singh R, Chen J, Srinual S, Yin T, Sun R, Hu M.
    Pharm Res; 2024 Sep; 41(9):1855-1867. PubMed ID: 39138788
    [Abstract] [Full Text] [Related]

  • 27. Reducing irinotecan-associated diarrhea in children.
    Wagner LM, Crews KR, Stewart CF, Rodriguez-Galindo C, McNall-Knapp RY, Albritton K, Pappo AS, Furman WL.
    Pediatr Blood Cancer; 2008 Feb; 50(2):201-7. PubMed ID: 17570704
    [Abstract] [Full Text] [Related]

  • 28. Bradycardia induced by irinotecan: a case report.
    Miya T, Fujikawa R, Fukushima J, Nogami H, Koshiishi Y, Goya T.
    Jpn J Clin Oncol; 1998 Nov; 28(11):709-11. PubMed ID: 9861240
    [Abstract] [Full Text] [Related]

  • 29. Treatment of childhood sarcoma with irinotecan: bilirubin level as a predictor of gastrointestinal toxicity.
    Ruggiero A, Coccia P, Scalzone M, Attinà G, Riccardi R.
    J Chemother; 2009 Dec; 21(6):693-7. PubMed ID: 20071295
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. St. John's wort and irinotecan-induced diarrhea.
    Birdsall TC.
    Toxicol Appl Pharmacol; 2007 Apr 01; 220(1):108; author reply 109-10. PubMed ID: 17276473
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment.
    Saliba F, Hagipantelli R, Misset JL, Bastian G, Vassal G, Bonnay M, Herait P, Cote C, Mahjoubi M, Mignard D, Cvitkovic E.
    J Clin Oncol; 1998 Aug 01; 16(8):2745-51. PubMed ID: 9704727
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.